|
1
|
Konstantinidis K, Whelan RS and Kitsis RN:
Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc
Biol. 32:1552–1562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cahill TJ and Kharbanda RK: Heart failure
after myocardial infarction in the era of primary percutaneous
coronary intervention: Mechanisms, incidence and identification of
patients at risk. World J Cardiol. 9:407–415. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bergsbaken T, Fink SL and Cookson BT:
Pyroptosis: Host cell death and inflammation. Nat Rev Microbiol.
7:99–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wree A, Eguchi A, McGeough MD, Pena CA,
Johnson CD, Canbay A, Hoffman HM and Feldstein AE: NLRP3
inflammasome activation results in hepatocyte pyroptosis, liver
inflammation, and fibrosis in mice. Hepatology. 59:898–910. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Man SM, Karki R and Kanneganti TD:
Molecular mechanisms and functions of pyroptosis, inflammatory
caspases and inflammasomes in infectious diseases. Immunol Rev.
277:61–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Azevedo PS, Polegato BF, Minicucci MF,
Paiva SAR and Zornoff LAM: Cardiac remodeling: Concepts, clinical
impact, pathophysiological mechanisms and pharmacologic treatment.
Arq Bras Cardiol. 106:62–69. 2016.PubMed/NCBI
|
|
8
|
Chen G, Li J, Song M, Wu Z, Zhang W, Wang
Z, Gao J, Yang Z and Ou C: A mixed component supramolecular
hydrogel to improve mice cardiac function and alleviate ventricular
remodeling after acute myocardial infarction. Adv Funct Materials.
27:17017982017.https://doi.org/10.1002/adfm.201701798 View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kale P and Afzal A: Stage B heart failure:
To strain or not to strain. JACC Cardiovasc Imaging. 11:1401–1404.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bujak M and Frangogiannis NG: The role of
TGF-beta signaling in myocardial infarction and cardiac remodeling.
Cardiovasc Res. 74:184–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dobaczewski MW, Chen W and Frangogiannis
NG: Transforming growth factor (TGF)-β signaling in cardiac
remodeling. J Mol Cell Cardiol. 51:600–606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Frangogiannis NG: The role of transforming
growth factor (TGF)-β in the infarcted myocardium. J Thorac Dis. 9
(Suppl 1):S52–S63. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Monzen K, Hiroi Y, Kudoh S, Akazawa H, Oka
T, Takimoto E, Hayashi D, Hosoda T, Kawabata M, Miyazono K, et al:
Smads, TAK1, and their common target ATF-2 play a critical role in
cardiomyocyte differentiation. J Cell Biol. 153:687–698. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mihaly SR, Ninomiya-Tsuji J and Morioka S:
TAK1 control of cell death. Cell Death Differ. 21:1667–1676. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okada M, Matsuzawa A, Yoshimura A and
Ichijo H: The lysosome rupture-activated TAK1-JNK pathway regulates
NLRP3 inflammasome activation. J Biol Chem. 289:32926–3236. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Toldo S, Mezzaroma E, Mauro AG, Salloum F,
Van Tassell BW and Abbate A: The inflammasome in myocardial injury
and cardiac remodeling. Antioxid Redox Signal. 22:1146–1161. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhaolin Z, Guohua L, Shiyuan W and Zuo W:
Role of pyroptosis in cardiovascular disease. Cell Prolif.
52:e125632019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mezzaroma E, Toldo S, Farkas D, Seropian
IM, Van Tassell BW, Salloum FN, Kannan HR, Menna AC, Voelkel NF and
Abbate A: The inflammasome promotes adverse cardiac remodeling
following acute myocardial infarction in the mouse. Proc Natl Acad
Sci USA. 108:19725–19730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu D, Zeng X, Li X, Mehta JL and Wang X:
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular
diseases. Basic Res Cardiol. 113:52018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ferrini A, Stevens MM, Sattler S and
Rosenthal N: Toward regeneration of the heart: Bioengineering
strategies for immunomodulation. Front Cardiovasc Med. 6:262019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McKenzie BA, Mamik MK, Saito LB, Boghozian
R, Monaco MC, Major EO, Lu JQ, Branton WG and Power C: Caspase-1
inhibition prevents glial inflammasome activation and pyroptosis in
models of multiple sclerosis. Proc Natl Acad Sci USA.
115:E6065–E6074. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sharma B, McLeland CB, Potter TM, Stern ST
and Adiseshaiah PP: Assessing NLRP3 inflammasome activation by
nanoparticles. Methods Mol Biol. 1682:135–147. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fann DY, Santro T, Manzanero S,
Widiapradja A, Cheng YL, Lee SY, Chunduri P, Jo DG, Stranahan AM,
Mattson MP and Arumugam TV: Intermittent fasting attenuates
inflammasome activity in ischemic stroke. Exp Neurol. 257:114–119.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu ZD, Ye JY, Niu H, Ma YM, Fu XM, Xia ZH
and Zhang X: Effects of microRNA-292-5p on myocardial
ischemia-reperfusion injury through the peroxisome
proliferator-activated receptor-α/-γ signaling pathway. Gene Ther.
25:234–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Volpe M, Carnovali M and Mastromarino V:
The natriuretic peptides system in the pathophysiology of heart
failure: From molecular basis to treatment. Clin Sci (Lond).
130:57–77. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zablocki D and Sadoshima J: Angiotensin II
and oxidative stress in the failing heart. Antioxid Redox Signal.
19:1095–1109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jones ES, Vinh A, McCarthy CA, Gaspari TA
and Widdop RE: AT2 receptors: Functional relevance in
cardiovascular disease. Pharmacol Ther. 120:292–316. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Michel MC, Brunner HR, Foster C and Huo Y:
Angiotensin II type 1 receptor antagonists in animal models of
vascular, cardiac, metabolic and renal disease. Pharmacol Ther.
164:1–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kompa AR, Lu J, Weller TJ, Kelly DJ, Krum
H, von Lueder TG and Wang BH: Angiotensin receptor neprilysin
inhibition provides superior cardioprotection compared to
angiotensin converting enzyme inhibition after experimental
myocardial infarction. Int J Cardiol. 258:192–198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shirley M and McCormack PL:
Perindopril/amlodipine (Prestalia®): A review in
hypertension. Am J Cardiovasc Drugs. 15:363–370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Campbell DJ: A review of perindopril in
the reduction of cardiovascular events. Vasc Health Risk Manag.
2:117–124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ishii M, Kaikita K, Sato K, Sueta D,
Fujisue K, Arima Y, Oimatsu Y, Mitsuse T, Onoue Y, Araki S, et al:
Cardioprotective effects of LCZ696 (Sacubitril/Valsartan) after
experimental acute myocardial infarction. JACC Basic Transl Sci.
2:655–668. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang PC, Lin SF, Chu Y, Wo HT, Lee HL,
Huang YC, Wen MS and Chou CC: LCZ696 therapy reduces ventricular
tachyarrhythmia inducibility in a myocardial infarction-induced
heart failure rat model. Cardiovasc Ther. 2019:60326312019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li W, Li Y, Chu Y, Wu W, Yu Q, Zhu X and
Wang Q: PLCE1 promotes myocardial ischemia-reperfusion injury in
H/R H9c2 cells and I/R rats by promoting inflammation. Biosci Rep.
39:BSR201816132019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi J, Zhao Y, Wang K, Shi X, Wang Y,
Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by
inflammatory caspases determines pyroptotic cell death. Nature.
526:660–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli
VG, Wu H and Lieberman J: Inflammasome-activated gasdermin D causes
pyroptosis by forming membrane pores. Nature. 535:153–158. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Malireddi R, Kesavardhana S and Kanneganti
TD: ZBP1 and TAK1: Master regulators of NLRP3
inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis).
Front Cell Infect Microbiol. 9:4062019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Orning P, Weng D, Starheim K, Ratner D,
Best Z, Lee B, Brooks A, Xia S, Wu H, Kelliher MA, et al: Pathogen
blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin
D and cell death. Science. 362:1064–1069. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bhatt AS, Ambrosy AP and Velazquez EJ:
Adverse remodeling and reverse remodeling after myocardial
infarction. Curr Cardiol Rep. 19:712017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li J, Cai SX, He Q, Zhang H, Friedberg D,
Wang F and Redington AN: Intravenous miR-144 reduces left
ventricular remodeling after myocardial infarction. Basic Res
Cardiol. 113:362018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Caporizzo MA, Chen CY, Bedi K, Margulies
KB and Prosser BL: Microtubules increase diastolic stiffness in
failing human cardiomyocytes and myocardium. Circulation.
141:902–915. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang YS, Zhao YH, Zhong Y, Li XZ, Pu JX,
Luo YC and Zhou QL: Neferine inhibits LPS-ATP-induced endothelial
cell pyroptosis via regulation of ROS/NLRP3/caspase-1 signaling
pathway. Inflamm Res. 68:727–738. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gao R, Shi H, Chang S, Gao Y, Li X, Lv C,
Yang H, Xiang H, Yang J, Xu L and Tang Y: The selective
NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and
improves cardiac remodeling in a mouse model of myocardial
infarction. Int Immunopharmacol. 74:1055752019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takahashi M: Role of NLRP3 inflammasome in
cardiac inflammation and remodeling after myocardial infarction.
Biol Pharm Bull. 42:518–523. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bai Y, Sun X, Chu Q, Li A, Qin Y, Li Y,
Yue E, Wang H, Li G, Zahra SM, et al: Caspase-1 regulates Ang
II-induced cardiomyocyte hypertrophy via up-regulation of IL-1β.
Biosci Rep. 38:BSR201714382018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cohn JN, Ferrari R and Sharpe N: Cardiac
remodeling-concepts and clinical implications: A consensus paper
from an international forum on cardiac remodeling. Behalf of an
international forum on cardiac remodeling. J Am Coll Cardiol.
35:569–582. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Schnee JM and Hsueh WA: Angiotensin II,
adhesion, and cardiac fibrosis. Cardiovasc Res. 46:264–268. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yamazaki T, Komuro I, Shiojima I and
Yazaki Y: The renin-angiotensin system and cardiac hypertrophy.
Heart. 76 (Suppl 3):S33–S35. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Brand T and Schneider MD: Transforming
growth factor-beta signal transduction. Circ Res. 78:173–179. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
da Silva PM and Aguiar C:
Sacubitril/valsartan: An important piece in the therapeutic puzzle
of heart failure. Rev Port Cardiol. 36:655–668. 2017.(In English,
Portuguese). PubMed/NCBI
|
|
52
|
Forte M, Madonna M, Schiavon S, Valenti V,
Versaci F, Zoccai GB, Frati G and Sciarretta S: Cardiovascular
pleiotropic effects of natriuretic peptides. Int J Mol Sci.
20:38742019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lee NS and Daniels LB: Current
understanding of the compensatory actions of cardiac natriuretic
peptides in cardiac failure: A clinical perspective. Card Fail Rev.
2:14–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ni J, Li Y, Xu Y and Guo R: Salidroside
protects against cardiomyocyte apoptosis and ventricular remodeling
by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse
model. Phytomedicine. 82:1534062021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xia P, Liu Y and Cheng Z: Signaling
pathways in cardiac myocyte apoptosis. Biomed Res Int.
2016:95832682016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jia C, Chen H, Zhang J, Zhou K, Zhuge Y,
Niu C, Qiu J, Rong X, Shi Z, Xiao J, et al: Role of pyroptosis in
cardiovascular diseases. Int Immunopharmacol. 67:311–318. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wu J, Lin S, Wan B, Velani B and Zhu Y:
Pyroptosis in liver disease: New insights into disease mechanisms.
Aging Dis. 10:1094–1108. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Guo H, Xie M, Zhou C and Zheng M: The
relevance of pyroptosis in the pathogenesis of liver diseases. Life
Sci. 223:69–73. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zheng Z and Li G: Mechanisms and
therapeutic regulation of pyroptosis in inflammatory diseases and
cancer. Int J Mol Sci. 21:14562020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Teng JF, Mei QB, Zhou XG, Tang Y, Xiong R,
Qiu WQ, Pan R, Law BYK, Wong VKW, Yu CL, et al: Polyphyllin VI
induces caspase-1-mediated pyroptosis via the induction of
ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer.
Cancers (Basel). 12:1932020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li A, Yu Y, Ding X, Qin Y, Jiang Y, Wang
X, Liu G, Chen X, Yue E, Sun X, et al: MiR-135b protects
cardiomyocytes from infarction through restraining the
NLRP3/caspase-1/IL-1β pathway. Int J Cardiol. 307:137–145. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tan M, Tan L, Jiang T, Zhu XC, Wang HF,
Jia CD and Yu JT: Amyloid-β induces NLRP1-dependent neuronal
pyroptosis in models of Alzheimer's disease. Cell Death Dis.
5:e1382. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Burdette D, Haskett A, Presser L, McRae S,
Iqbal J and Waris G: Hepatitis C virus activates interleukin-1beta
via caspase-1-inflammasome complex. J Gen Virol. 93:235–246. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Theofani E, Semitekolou M, Morianos I,
Samitas K and Xanthou G: Targeting NLRP3 inflammasome activation in
severe asthma. J Clin Med. 8:16152019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Malireddi RS, Gurung P, Mavuluri J, Dasari
TK, Klco JM, Chi H and Kanneganti TD: TAK1 restricts spontaneous
NLRP3 activation and cell death to control myeloid proliferation. J
Exp Med. 215:1023–1034. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Malireddi R, Gurung P, Kesavardhana S,
Samir P, Burton A, Mummareddy H, Vogel P, Pelletier S, Burgula S
and Kanneganti TD: Innate immune priming in the absence of TAK1
drives RIPK1 kinase activity-independent pyroptosis, apoptosis,
necroptosis, and inflammatory disease. J Exp Med. 217:201916442020.
View Article : Google Scholar
|
|
67
|
Yang Y, Wang, Kouadir M, Song H and Shi F:
Recent advances in the mechanisms of NLRP3 inflammasome activation
and its inhibitors. Cell Death Dis. 10:1282019. View Article : Google Scholar : PubMed/NCBI
|
